The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Roivant Sciences announced several updates for trial evaluating the impact of IV treatment with gimsilumab on mortality in COVID-19 patients with lung...
read more
ReGenTree and RegeneRx announced the results of a Phase 3 clinical trial using RGN-259 for neurotrophic keratopathy.
read more
Akers Biosciences announced Premas Biotech, its partner in the development of a vaccine candidate that is seeking to address the COVID-19 pandemic, ...
read more
Blueprint Medicines announced the FDA has issued a CRL for the new drug application of avapritinib for unresectable or metastatic fourth-line ...
read more
Review the latest news and information on the Coronavirus Pandemic.
read more
Adamas has been issued a new patent by the USPTO that covers GOCOVRI extended release capsules.
read more
Rhythm announced the FDA has accepted the company's NDA for setmelanotide.
read more
Enzychem Lifesciences announced the MFDS has accepted its IND application to initiate a Phase 2 study for its lead therapeutic candidate in Preventing...
read more
Sorrento announced anti-SARS-CoV-2 antibody, STI-1499, demonstrated 100% inhibition of SARS-CoV-2 virus infection in an in vitro virus infection ...
read more
Review the latest news and information on the Coronavirus Pandemic.
read more
A research team led by HKBU has developed a novel anti-EBV drug that can selectively disrupt a viral protein produced by EBV.
read more
Neurocrine Biosciences and Idorsia announced, following IND application acceptance by the FDA, Neurocrine Biosciences has exercised its option to ...
read more
Review the latest news and information on the Coronavirus Pandemic.
read more
Review the latest news and information on the Coronavirus Pandemic.
read more
Eli Lilly announced the FDA approved Retevmo for metastatic rearranged during transfection fusion-positive NSCLC and advanced or metastatic RET-mutant...
read more